Location and Dates
- Location: Ottignies-Louvain-la-Neuve, Belgium
- Program Dates: May 19 - June 15, 2024
- Term(s) Offered: Summer I
- Applicable Major(s): Biomedical engineering and pending others. Please contact your advisor for approval to see how this course fits your academic path.
- Prerequisites: Admitted to major degree sequence (upper-level) in biomedical engineering. To be determined regarding waiver or prerequisites for non-biomedical engineering majors.
- GPA: 2.5 (or instructor approval)
- Application Deadline: Feb. 1, 2024
-
Overview
This program is a study of entrepreneurial pathways and business issues in medical device commercialization with a specific focus on European and other key global medical device markets, with attention to the regulatory knowledge necessary to enable the development of an appropriate strategy in the highly regulated global environment.
The medical device industry is subject to numerous business constraints and regulatory controls on how products must be developed, approved, brought to market, surveilled during their commercial lifespan, and retired. Though global harmonization of regulations is a continuing effort, these constraining factors are often unique and specific to medical devices and products in each global region.
Courses Offered
To view the specific requirements, click on the link below.
Estimated Cost
-
Contact Information
Faculty Leaders
Dr. Saurab Biswas
Biomedical Engineering
saurabh_biswas@tamu.eduProgram Coordinators
Halliburton Engineering Global Programs
Zachry Engineering Education Complex
Suite 410
engineeringglobalprograms@tamu.edu